Near Infrared Spectroscopy in Medical Diagnostics

Similar documents
Chandra Ramamoorthy MBBS; FRCA (UK) Professor of Anesthesiology, Stanford University. Director of Pediatric Cardiac Anesthesiology

Oximeters. Hsiao-Lung Chan, Ph.D. Dept Electrical Engineering Chang Gung University, Taiwan

INVOS System Inservice Guide for Pediatric Use. INVOS System Inservice Guide for Pediatric Use

Oximeters. Hsiao-Lung Chan, Ph.D. Dept Electrical Engineering Chang Gung University, Taiwan

Advanced Monitoring of Cardiovascular and Respiratory Systems in Infants Kuwait 2018 Dr. Yasser Elsayed, MD, PhD Director of the Targeted Neonatal

Introduction. Invasive Hemodynamic Monitoring. Determinants of Cardiovascular Function. Cardiovascular System. Hemodynamic Monitoring

What is. InSpectra StO 2?

Near-Infrared Monitoring of Brain and Tissue Oxygenation: Is the Monitor on the Right Person?

Evidence-Based. Management of Severe Sepsis. What is the BP Target?

NEONATAL MONITORING IN-SERVICE GUIDE

How Does Pulse Oximetry Work? SpO2 Sensors Absorption at the Sensor Site Oxyhemoglobin Dissociation Curve

NIRS of the brain new diagnostic tool

Near Infrared Spectroscopy in Neonatal Intensive Care

SHOCK. Emergency pediatric PICU division Pediatric Department Medical Faculty, University of Sumatera Utara H. Adam Malik Hospital

Multimodal Brain Monitoring with NIRS and aeeg and their Clinical Significance

How to maintain optimal perfusion during Cardiopulmonary By-pass. Herdono Poernomo, MD

Disclosures. Set up audience participation. Test question. Outline. Neuromonitoring What and When? IP for monitoring technology licensed to Medtronic

Appendix E Choose the sign or symptom that best indicates severe respiratory distress.

Absolute Cerebral Oximeters for Cardiovascular Surgical Cases

When Cyanosis is the Norm. Steven M. Schwartz, MD, FRCPC Cardiac Critical Care Medicine The Hospital for Sick Children Toronto

NEONATAL CLINICAL PRACTICE GUIDELINE

CEREBRAL OXIMETRY IN INFANTS WITH HIE DAPHNA YASOVA BARBEAU, MD FN3 MEETING 2018

Critical Care Monitoring. Assessing the Adequacy of Tissue Oxygenation. Tissue Oxygenation - Step 1. Tissue Oxygenation

Biomedical Instrumentation D. The Photoplethysmogram

Dr. Puntarica Suwanprathes. Version 2007

Oxygen Saturation Monitors & Pulse Oximetry. D. J. McMahon rev cewood

Transfusion Limbo How Low Will You Go? Safely. Nina A. Guzzetta, M.D. Children s Healthcare of Atlanta Emory University School of Medicine

Post-Cardiac Surgery Evaluation

UTILITY of ScvO 2 and LACTATE

Use of Blood Lactate Measurements in the Critical Care Setting

Objective 2/9/2012. Blood Gas Analysis In The Univentricular Patient: The Need For A Different Perspective. VENOARTERIAL CO2 GRADIENT

3. Which of the following would be inconsistent with respiratory alkalosis? A. ph = 7.57 B. PaCO = 30 mm Hg C. ph = 7.63 D.

Case scenario V AV ECMO. Dr Pranay Oza

Mechanical Ventilation. Assessing the Adequacy of Tissue Oxygenation. Tissue Oxygenation - Step 1. Tissue Oxygenation

Conventional vs. Goal Directed Perfusion (GDP) Management: Decision Making & Challenges

ALCO Regulations. Protocol pg. 47

ECMO Primer A View to the Future

I have no relevant financial relationships with the manufacturers of any. commercial products and/or provider of commercial services discussed in

Case year old female nursing home resident with a hx CAD, PUD, recent hip fracture Transferred to ED with decreased mental status BP in ED 80/50

Module G: Oxygen Transport. Oxygen Transport. Dissolved Oxygen. Combined Oxygen. Topics to Cover

Current bedside monitors of brain blood flow and oxygen delivery

Are Patients Hypoperfused in the ED? Rapid Perfusion Assessment in the Emergency Department

State of Florida Systemic Supportive Care Guidelines. Michael D. Weiss, M.D. Associate Professor of Pediatrics Division of Neonatology

Perioperative Management of TAPVC

Cerebral Oximetry in Preterm Infants: Methods, Measurements and Evaluating Clinical Benefit

Perioperative Management of DORV Case

Pediatric Septic Shock. Geoffrey M. Fleming M.D. Division of Pediatric Critical Care Vanderbilt University School of Medicine Nashville, Tennessee

7/4/2015. diffuse lung injury resulting in noncardiogenic pulmonary edema due to increase in capillary permeability

Why Old Blood is Bad. tales from the electronic perfusion record. Molly Marko, BS, BSE, CCP Geisinger Health System Danville, Pennsylvania

Does Targeted Neonatal Echocardiography(TnECHO) can help prevent Postoperative Cardiorespiratory instability following PDA ligation?

Near-Infrared Spectroscopy (NIRS) in the Neonatal Intensive Care Unit: Tissue Oxygenation Physiology and Monitoring Approaches

ECLS Registry Form Extracorporeal Life Support Organization (ELSO)

5. What is the cause of this patient s metabolic acidosis? LACTIC ACIDOSIS SECONDARY TO ANEMIC HYPOXIA (HIGH CO LEVEL)

What would be the response of the sympathetic system to this patient s decrease in arterial pressure?

(Peripheral) Temperature and microcirculation

Pediatric emergencies (SHOCK & COMA) Dr Mubarak Abdelrahman Assistant Professor Jazan University

Cardiovascular Nursing Practice: A Comprehensive Resource Manual and Study Guide for Clinical Nurses 2 nd Edition

Staging Sepsis for the Emergency Department: Physician

Heinz-Hermann Weitkemper, EBCP. 4th Joint Scandinavian Conference in Cardiothoracic Surgery 2012 Vilnius / Lithuania

Muscle OxyGen monitor. The Science Behind Moxy

Hybrid Stage I Palliation / Bilateral PAB

SUBJECT INFORMATION AND CONSENT FORM

Post Cardiac Arrest Care 2015 American Heart Association Guideline Update for CPR and Emergency Cardiovascular Care

The Pharmacology of Hypotension: Vasopressor Choices for HIE patients. Keliana O Mara, PharmD August 4, 2018

การอบรมว ทยาศาสตร พ นฐานทางศ ลยศาสตร เร อง นพ.ส ณฐ ต โมราก ล ภาคว ชาว ส ญญ ว ทยา คณะแพทยศาสตร โรงพยาบาลรามาธ บด มหาวทยาลยมหดล

CEA and cerebral protection Volodymyr labinskyy, MD

ECMO CPR. Ravi R. Thiagarajan MBBS, MPH. Cardiac Intensive Care Unit

Defining Optimal Perfusion during CPB. Carlo Alberto Tassi Marketing Manager Eurosets Italy

State of the Art Multimodal Monitoring

Hemodynamic Monitoring

Hypotension in the Neonate

Pulse. Assess for the following:

Goal-directed vs Flow-guidedresponsive

Fluids in Sepsis: How much and what type? John Fowler, MD, FACEP Kent Hospital, İzmir Eisenhower Medical Center, USA American Hospital Dubai, UAE

Anatomy & Physiology

Failure of the circulation to maintain Tissue cellular. Tissue hypoperfusion Cellular hypoxia SHOCK. Perfusion

Hypothermia in Neonates with HIE TARA JENDZIO, DNP(C), RN, RNC-NIC

When is Risky to Apply Oxygen for Congenital Heart Disease 부천세종병원 소아청소년과최은영

Pulse oximetry revisited. Dr Liesel Bösenberg Specialist Physician and Fellow in Critical Care Kalafong Hospital University of Pretoria

The Septic Patient. Dr Arunraj Navaratnarajah. Renal SpR Imperial College NHS Healthcare Trust

NIRS utilization during first hours and days of life

Lisa T. Hannegan, MS, CNS, ACNP. Department of Neurological Surgery University of California, San Francisco

Stabilization and Transportation guidelines for Neonates and infants with Heart disease:

The first oximetry system to put regional oximetry, pulse oximetry and ease of use at your fingertips.

Acute Liver Failure: Supporting Other Organs

Duct Dependant Congenital Heart Disease

Objectives. Epidemiology of Sepsis. Review Guidelines for Resuscitation. Tx: EGDT, timing/choice of abx, activated

Management of a Patient after the Bidirectional Glenn

Duct Dependant Congenital Heart Disease

The Hemodynamic Puzzle

Ajay Yadlapati, MD;* Tristan Grogan, MS; David Elashoff, PhD; Robert B. Kelly, MD

Cardiovascular System. Blood Vessel anatomy Physiology & regulation

PHYSIOLOGY AND MANAGEMENT OF THE SEPTIC PATIENT

Screening for Critical Congenital Heart Disease

I intend to discuss an unapproved/investigative use of a commercial product/device in my presentation

SenSmart Model X-100. The first oximetry system to put regional oximetry, pulse oximetry and ease of use at your fingertips.

MANAGEMENT OF CIRCULATORY FAILURE

Optical Sensor System for Hemoglobin Measurement

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

Oximetry. Jan Bakker. Grants Hutchinson Pulsion.

Transcription:

Near Infrared Spectroscopy in Medical Diagnostics Michael D. Wider, PhD Vice President Of Technology Somanetics Corporation Adjunct Assistant Professor in Physiology Wayne State University School of Medicine

Presenter Disclosures The following relationships with commercial interest related to this presentation existed during the past 12 months: Full time employee of Somanetics Corporation. Shareholder of stock and options Somanetics Corporation. NIRS patent pending. The following FDA disclosures related to this presentation exist: All NIRS equipment referenced is FDA approved for use on all patients including neonates. Animal studies presented are investigational.

Near Infrared Spectroscopy NIR Spectroscopy What is it? What does it measure? How accurate is it? What are the limitations? Tissue Monitoring - Animal studies Clinical Evidence

Beer s Law

Near Infrared Spectroscopy - NIRS 700 to 1000 nm wavelength light Bond specific Few molecules absorb at this wavelength Iron containing heme ring H2O at >900 nm

Near Infrared

NIRS Specific Hb/HbO2 Accurate validation data in human subjects Sensitive extreme sensitivity to change in human subjects and animal model - R 2 0.96

What does it measure? rso 2 - regional hemoglobin oxygen saturation in tissue under the sensor - % saturation - Does NOT measure Hb concentration 25% arterial / 75% venous rso 2 venous weighted, no standard value SvO2 no standard value flow / metabolism coupled Tissue Hb saturation delivery / consumption Reflects perfusion distribution

Specific Overtone bands with extremely low molar absorptivity

Hemoglobin Molar Absorptivity

Analyte Specificity Lipids show minimal absorption by hydrocarbons at 700-880 nm.

Sensors

Light Emitting Diode

Laser Diodes with Fiber Optics

Photodiode

Cerebral Oximetry Diffuse Reflectance Spectroscopy

Spatial Resolution Spatially Resolved NIRS Multiple detectors spatially localize the measurement of brain oxygenation deep-shallow detector compensation isolates brain signals from scalp and surface matter External Carotid Artery Dye Injection Internal Carotid Artery Dye Injection Deep Signal Shallow Signal Deep-Shallow Difference (Represents Brain Signal) Hongo K et al. 1995 Neurol Res 1995,17:89-93.

Accurate - Validation Abdul-Kaliq H et al. Biomed Tech (Berl); 2000; 45; 328-32 Average age 4.5 years (n=30)

Sensitive 50 % CrSO 2 Change 40 30 20 10 0-10 -20-30 -40 Transitions, 22 Pts, 90 Points y = 1.0372x - 0.0062 R 2 = 0.9609 Bias = -0.02 Std Dev = 1.63-50 -40-30 -20-10 0 10 20 30 40 % fso 2 Change fso2 = field saturation (25% arterial:75% venous)

Measuring Oxygen Hb = hemoglobin (Hb) concentration in grams pre 100 ml blood PO 2 = partial pressure of oxygen (mm Hg) in air or liquid PaO 2 = Arterial partial pressure of dissolved oxygen in plasma (mm Hg) SO 2 = % saturation of Hb with oxygen SpO 2 = % saturation of Hb in arterial blood measured by pulse oximetry SaO 2 = % saturation of Hb in arterial blood SvO 2 = % saturation of Hb in mixed venous blood SjvO 2 = % saturation of Hb in jugular vein blood FiO 2 = fraction of oxygen in inspired air at sea level CaO2 = total Oxygen content of arterial blood DO 2 = Delivered oxygen rso 2 = amount of hemoglobin bound oxygen in tissue

Arterial vs Tissue HbO 2 Related but different issues - supply vs demand Clinical emphasis on O 2 supply blood gas, pulse ox Defined interventions for supply side SpO 2 fix the number and you fix the problem rso 2 perfusion balance / AV difference Arterial O 2 doesn t guarantee tissue O 2

Absolute Venous Saturation? While there is an absolute number or target saturation for arterial blood (SpO2 = 98%) there is no absolute number for venous saturation. SvO 2 depends on flow, ph, 2,3 DPG, Hb form, Hb concentration, vascular abnormalities, capillary exchange, tissue O2 demand, autoregulation, etc. Arterial Hb saturation does not guarantee sufficient O2 delivery.

Baselines Normal Cerebral rso 2 rso2 + SE 90.0 80.0 70.0 60.0 50.0 40.0 30.0 20.0 10.0 0.0 Dark Sk in Light Skin Male Fem ale Total n=76 n=138 n=50 n=175 n=225 Normal, ambulatory adults (n=225)

Thresholds Following are the most recognized values published in the pediatric arena most often on congenital heart patients. Cerebral Typical range: 60-80; assuming SpO 2 is >90 < 50 rso 2 or 20% from rso 2 baseline < 45 rso 2 or 25% from rso 2 baseline is critical threshold Somatic Response to intervention Watch for drops 20% below patient baseline Hoffman GM, et al. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2005:12-21. Hoffman GM, et al. Anesthesiology 2005;103:A1327. Petrova A and Mehta R. Pediatr Crit Care Med 2006;7:449-454. Dent CL, et al. J Thorac Cardiovasc Surg. 2006 Jan;131(1):190-7. Data on file.

Piglet Model Yorkshire- Duroc blend Michigan State University 1.5 10 kg 1 to 30 days old Accepted model of human infant Very similar biology and anatomy 1-5 days old - very unstable Anesthetized vs unanesthetized

Piglet Model Fully Instrumented Temp Invasive BP HR SpO 2 SvO 2 co-oximeter SaO 2 co-oximeter ET-CO 2 Electrolytes Blood gases Lactate Glucose

Piglet Cerebral rso 2 Validation Cumulative CrSO2 vs SijvO 2 CrSO2 100 90 80 70 60 50 40 30 20 10 0 y = 0.9131x + 2.5908 R 2 = 0.9076 piglets 1.1 to 5.4 kg n = 5 0 10 20 30 40 50 60 70 80 90 100 SijvO 2

Normal Piglet 100 Normal Piglet (Avg n=4) 90 80 70 60 rso2 50 40 30 20 10 0 0:00 0:20 0:40 1:00 1:20 1:40 2:00 2:20 2:40 3:00 3:20 3:40 4:00 Head Leg Kidney Gut

Cerebral Ischemia 10 0 90 021508 Carotid Occlusion bilateral occlusion unilateral occlusion 3.5 kg piglet 80 70 rso2 60 50 40 Head Liver Kidney Gut 30 20 10 Release 0 Time

Functional and Biochem Ischemic Thresholds FIG. 5. Logistic regression plot between near-infrared spectros-copy ScO2 and the percent of piglets without minor change in EEG activity or without major change in EEG activity compared with baseline. Data points indicate mean ± SD. Logistic regres-sion equation variables are presented in Table 2. FIG. 6. Logistic regression plot between near-infrared spectros-copy ScO2 and the percent of piglets with normal brain tissue lactate concentrations and normal brain tissue ATP concentra-tions. Data points indicate mean ± SD. Logistic regression equa-tion variables are presented in Table 2. Kurth CD, Levy WJ and McCann J. 2002 J Cerebral Blood Flow and Metab 22; 335-341

Hou X et al. 2007. Physiol Measures 28; 1251-1265 Structural Ischemic Thresholds ~2.2 kg piglets >60% 40-50% 35-40% 30-35%

Renal Ischemia 113007 Renal Ischemia 2.7 kg piglet 10 0 90 rso 2 80 70 60 50 40 artery released Cerebral Gut Kidney Muscle 30 20 renal artery occluded artery released 10 0 Time

Abdominal Ischemia 90 102407 am Ischemic Gut 1.9 kg piglet 80 70 60 rso2 50 40 Right abdomen Right leg 30 20 10 0 time

Hypovolemia 021508 Hypovolemia 3.5 kg piglet 10 0 60 cc 40 cc 20 cc 10 cc 10 cc 8 cc 10 cc FA 90 80 70 rso 2 60 50 40 Head Liver Kidney Gut 30 20 10 SpO 2 93 HR 181 MAP 66 SpO 2 9 HR 212 MAP 56 SpO 2 95 HR 241 MAP 50 Sf vo 2 35 Sf ao 2 93 SpO 2 93 HR 254 MAP 44 Sf vo 2 23 SpO 2 93 HR 277 MAP 62 SpO 2 92 HR 270 MAP 58 SpO 2 92 MAP 36 HR 246 Sf vo 2 30 Sf ao 2 94 SpO2 92 HR 279 MAP 42 SpO2 of f HR 231 MAP 25 Si j vo 2 25 0 Time

Anemia Infant Sensor 061808 Anemia 1.4 kg piglet 90 80 70 20 cc blood draw 60 cc LRS infused with each blood draw 25 cc blood draw 20 cc blood draw Euthanasia 12.0 10.0 60 25 cc blood draw 8.0 50 40 30 20 10 0 13:19 13:30 13:41 13:52 14:03 14:14 14:26 14:37 14:48 14:59 15:10 15:21 15:32 15:43 rso2 6.0 Hb (gm/dl) 45 cc blood infused 4.0 25 cc blood reinfused 2.0 0.0 Head Leg Kidney Gut Hb

Anemia Baseline 100 90 80 70 60 091708 Shock Study Baseline 1.6 kg piglet rso2 50 40 30 20 10 1/4 NS + D5W Total Hb 4.8 gm/dl 0 12:00 12:27 12:55 13:23 13:50 Time 14:18 14:46 15:13 15:41 16:09 Head Leg Kidney Gut

Using NIRS Look at the rso2 first Cerebral, perirenal and gut Perfusion distribution Then decide how the other clinical variables relate Decide on interventions based on all clinical data

Diagnostic Use Rule Out Perirenal rso 2 decline with acceptable cerebral rso 2 Reduced peripheral perfusion, autoregulation keeping up GA, Day of life, SpO 2, CHD (PDA, septal defect, FO) shunt, drugs, sepsis, FiO 2 Perirenal rso 2 decline with cerebral rso 2 decline Reduced global O 2 delivery GA, DOL, SpO 2, CHD, myocardial failure, drugs, sepsis, Cerebral rso 2 decline with minimal perirenal rso 2 change CO 2, cooling, sedation, drugs, brain death Cerebral and perirenal rso 2 stable abdominal rso 2 of 15 25 Ominous sign of gut ischemia if prolonged Swelling, ascites, sepsis, drain, antibiotics, feeds,

MRI Brain Lesions and rso 2 Preop MRI (n =22) demonstrated ischemic lesions in 23% of patients. Postoperative (Norwood) MRI (n =15) demonstrated new or worsened ischemic lesions in 73% of patients Periventricular leukomalacia and focal ischemic lesions most common Prolonged low postoperative rso 2 (45% for 180 minutes) associated with the development of new or worsened ischemia on postoperative MRI (P =.029) Prolonged low postoperative rso2 was a more predictive indicator of neurologic damage than today s traditional OR and CICU measures...post-op cerebral oximetry seems to offer value as a standard of care following the Norwood procedure or other surgical interventions that may impair cardiac output. Dent CL et al. 2006 J Thorac Cardiovasc Surg 131; 190-197

Post Norwood Outcome P < 0.0001 Adverse outcome was defined as hospital death, need for extracorporeal membrane oxygenation or cardiac intensive care unit length of stay greater than 30 days. Phelps HM et al. 2009 Ann Thorac Surg 87; 1490-1494

Neonatal Baselines Vanderbilt University study Susannah McNeal et al. 2009 12 premature neonates, 29-34 wks GA First 21 days of life Cerebral, renal and gut mean daily avg rso 2 Cerebral and renal decline 10 pts over first 2 weeks of life 29-30 vs 32-33 wks GA - gut rso 2 p< 0.005 Gut rso 2 variability decreases over first 2 weeks

Perirenal Tissue Ischemia Predicted Probabilities and 95% CI POD 3 Creatinine Doubling 0.2.4.6.8 1 Somatic rso2 vs. Renal Function 20 40 60 80 100 POD0 Somatic rso2 Predicted Value 95% CI Hoffman GM, et al. Anesthesiology 2005;103:A1327

Separation from ECMO rso 2 Underlying data and case notes on file ISC-10005. Data on file. Time

Pleural Effusion Following ASD/VSD Repair rso 2 Data on file. Time

Early Warning Neonate with Cardiac Defects - Early Indicator 100 Tetrology of Fallot, Pulmonary Atresia and Coarctation of the Aorta. 90 80 70 no change in map (37) map remains (37-40) cardiac arrest no wave form on art line 60 rso2 50 40 30 Pt. sx and assessed x ray 20 10 Pt sx and assessed bilateral grade three-four head bleed 0 15 mcg/kg of dopamine, epinephrine and hydrocortisone for blood pressure support. 0:00 2:12 4:25 6:39 8:52 11:05 13:18 15:31 17:44 19:57 22:10 cerebral perirenal

NICU Statistics Kirkby S et al. 2007 Advances in Neonatal Care 7; 80-87

R Nachar Hidalgo, M Wider, E Booth, S Drake, I Seri 2009 Cerebral rso 2 Drug Response (n=3) 100 Cerebral rso 2 Drug Response 90 80 70 60 50 40 30 Dobutamine Dopamine Milrinone Epinephrine Norepinephrin e 20 10 IV Drug Infusion 0 5 10 15 20 25 30 0:00 0:15 0:30 0:45 1:00 1:15 1:30 1:45 2:00 TIME

R Nachar Hidalgo, M Wider, E Booth, S Drake, I Seri 2009 Perirenal rso 2 Drug Response (n=3) 100 Perirenal rso 2 Drug Response 90 80 70 60 50 40 30 Dobutamine Dopamine Milrinone Epinephrine Norepinephrin e 20 10 IV Drug Infusion 0 5 10 15 20 25 30 0:00 0:15 0:30 0:45 1:00 1:15 1:30 1:45 2:00 TIME

R Nachar Hidalgo, M Wider, E Booth, S Drake, I Seri 2009 Gut rso 2 Drug Response (n=3) 100 Gut rso 2 Drug Response (n=3) 90 80 70 60 50 40 30 Dobutamine Dopamine Milrinone Epinephrine Norepinephrin e 20 10 IV Drug Infusion 0 5 10 15 20 25 30 0:00 0:15 0:30 0:45 1:00 1:15 1:30 1:45 2:00 TIME

R Nachar Hidalgo, M Wider, E Booth, S Drake, I Seri 2009 Gut rso 2 Drug Response (n=3) 100 Muscle rso 2 Drug Response (n=3) 90 80 70 60 50 40 30 Dobutamine Dopamine Milrinone Epinephrine Norepinephrin e 20 10 IV Drug Infusion 0 5 10 15 20 25 30 0:00 0:15 0:30 0:45 1:00 1:15 1:30 1:45 2:00 TIME

R Nachar Hidalgo, M Wider, E Booth, S Drake, I Seri 2009 Invasive BP Drug Response (n=3) 130 MAP Drug Response (n=3) 120 110 100 90 80 70 60 50 40 Dobutamine Dopamine Milrinone Epinephrine Norepinephrin e 30 20 10 IV Drug Infusion 0 5 10 15 20 25 30 0:00 0:15 0:30 0:45 1:00 1:15 1:30 1:45 2:00 TIME